Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Investigational New Drugs
|
January 1, 1984
Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in advanced breast cancer. A Phase II trial of the Southwest Oncology Group
W A Knight, R M O'Bryan, B Samal, et al.
Cancer Treatment Reports
|
November 1, 1977
Phase II trial of Baker's antifol in metastatic sarcoma
J T Thigpen, R M O'Bryan, R S Benjamin, et al.
Journal of Neuro-Oncology
|
January 1, 1983
Phase II study of cisplatin in recurrent astrocytomas in adults: a Southwest Oncology Group Study
D J Stewart, R M O'Bryan, M Al-Sarraf, et al.
Cancer
|
November 1, 1983
Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest Oncology Group study
R M Bukowski, S P Balcerzak, R M O'Bryan, et al.
Journal of Neuro-Oncology
|
January 1, 1985
Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group Study
S A Taylor, J D McCracken, H J Eyre, et al.
Investigational New Drugs
|
January 1, 1986
High dose AZQ in renal cancer. A Southwest Oncology Group phase II study
R L Stephens, R Kirby, E D Crawford, et al.
Investigational New Drugs
|
January 1, 1984
Southwest Oncology Group study of Mitoxantrone for treatment of patients with advanced squamous cell carcinoma of the head and neck
D E Mattox, G M Clark, S P Balcerzak, et al.
Oncology Nursing Forum
|
October 1, 1993
Pitfalls in quality-of-life assessment: lessons from a Southwest Oncology Group breast cancer clinical trial
K A Hayden, C M Moinpour, B Metch, et al.
Cancer Treatment Reports
|
June 1, 1985
Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: a Southwest Oncology Group Study
J K Weick, J M Rainey, R B Livingston, et al.
Cancer Treatment Reports
|
January 1, 1983
Management of patients with metastatic adenocarcinoma of unknown origin: a Southwest Oncology Group study
R A Shildt, P S Kennedy, T T Chen, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Investigational New Drugs
|
January 1, 1984
Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in advanced breast cancer. A Phase II trial of the Southwest Oncology Group
W A Knight, R M O'Bryan, B Samal, et al.
Cancer Treatment Reports
|
November 1, 1977
Phase II trial of Baker's antifol in metastatic sarcoma
J T Thigpen, R M O'Bryan, R S Benjamin, et al.
Journal of Neuro-Oncology
|
January 1, 1983
Phase II study of cisplatin in recurrent astrocytomas in adults: a Southwest Oncology Group Study
D J Stewart, R M O'Bryan, M Al-Sarraf, et al.
Cancer
|
November 1, 1983
Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest Oncology Group study
R M Bukowski, S P Balcerzak, R M O'Bryan, et al.
Journal of Neuro-Oncology
|
January 1, 1985
Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group Study
S A Taylor, J D McCracken, H J Eyre, et al.
Investigational New Drugs
|
January 1, 1986
High dose AZQ in renal cancer. A Southwest Oncology Group phase II study
R L Stephens, R Kirby, E D Crawford, et al.
Investigational New Drugs
|
January 1, 1984
Southwest Oncology Group study of Mitoxantrone for treatment of patients with advanced squamous cell carcinoma of the head and neck
D E Mattox, G M Clark, S P Balcerzak, et al.
Oncology Nursing Forum
|
October 1, 1993
Pitfalls in quality-of-life assessment: lessons from a Southwest Oncology Group breast cancer clinical trial
K A Hayden, C M Moinpour, B Metch, et al.
Cancer Treatment Reports
|
June 1, 1985
Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: a Southwest Oncology Group Study
J K Weick, J M Rainey, R B Livingston, et al.
Cancer Treatment Reports
|
January 1, 1983
Management of patients with metastatic adenocarcinoma of unknown origin: a Southwest Oncology Group study
R A Shildt, P S Kennedy, T T Chen, et al.
Page
of 3